- KOL and principal investigator, Dr. Farrukh Awan, Professor of Medicine, Division of Hematology Oncology at University of Texas Southwestern to join Actinium management on the webinar - Webinar ...

B.Riley Financial analyst Yuan Zhi has reiterated their bullish stance on ATNM stock, giving a Buy rating yesterday. Yuan Zhi has given his Buy rating due to a combination of factors involving ...

A man and woman are facing charges related to a fatal November shooting in Frisco that authorities have said appeared to be random. Jhirrell Harris and Stephanie Gayden, both of Monroe, Louisiana ...

Actinium Pharmaceuticals is a late-stage biopharmaceutical company focused on developing radiotherapies for AML patients. The company's leading product candidate, Iomab-B, has shown promising ...

(RTTNews) - Actinium Pharmaceuticals Inc. (ATNM) said that median overall survival of 5.49 months observed in patients with a TP53 mutation receiving an Iomab-B led allogeneic bone marrow ...

- KOL and principal investigator, Dr. Farrukh Awan, Professor of Medicine, Division of Hematology Oncology at University of Texas Southwestern to join Actinium management on the webinar - Webinar to ...

Situated between Warren Parkway and John Hickman Parkway, the Towers at Frisco Station will be a district of multiple large office buildings — potentially 3 million square feet in all. Check out ...

A dealership's rating is based on all of their reviews, with more weight given to recent reviews. Includes reviews of Frisco Chrysler Dodge Jeep Ram from DealerRater. Want to share your experience ...

Plans for the next phase of the Frisco Station mixed-use hub are coming into focus. Office space, a hotel and retail space — including four high-end dining options — are slated for the ...

(RTTNews) - Actinium Pharmaceuticals Inc. (ATNM) said that median overall survival of 5.49 months observed in patients with a TP53 mutation receiving an Iomab-B led allogeneic bone marrow ...